S&P 500   3,331.64 (-0.60%)
DOW   27,383.96 (-0.73%)
QQQ   276.30 (-0.32%)
AAPL   114.04 (-0.80%)
MSFT   208.34 (-0.53%)
FB   258.88 (+0.80%)
GOOGL   1,458.31 (-0.02%)
AMZN   3,165.82 (-0.26%)
TSLA   426.36 (+1.23%)
NVDA   526.98 (+1.07%)
BABA   277.69 (+0.61%)
CGC   14.60 (+2.74%)
MU   50.67 (+1.91%)
GE   6.07 (-2.10%)
AMD   81.42 (+2.44%)
T   28.17 (-0.74%)
F   6.57 (-1.79%)
ACB   4.97 (+3.97%)
GILD   62.16 (-1.10%)
NFLX   490.58 (-0.01%)
DIS   124.00 (-1.58%)
BA   162.84 (-1.95%)
BAC   23.61 (-1.99%)
S&P 500   3,331.64 (-0.60%)
DOW   27,383.96 (-0.73%)
QQQ   276.30 (-0.32%)
AAPL   114.04 (-0.80%)
MSFT   208.34 (-0.53%)
FB   258.88 (+0.80%)
GOOGL   1,458.31 (-0.02%)
AMZN   3,165.82 (-0.26%)
TSLA   426.36 (+1.23%)
NVDA   526.98 (+1.07%)
BABA   277.69 (+0.61%)
CGC   14.60 (+2.74%)
MU   50.67 (+1.91%)
GE   6.07 (-2.10%)
AMD   81.42 (+2.44%)
T   28.17 (-0.74%)
F   6.57 (-1.79%)
ACB   4.97 (+3.97%)
GILD   62.16 (-1.10%)
NFLX   490.58 (-0.01%)
DIS   124.00 (-1.58%)
BA   162.84 (-1.95%)
BAC   23.61 (-1.99%)
S&P 500   3,331.64 (-0.60%)
DOW   27,383.96 (-0.73%)
QQQ   276.30 (-0.32%)
AAPL   114.04 (-0.80%)
MSFT   208.34 (-0.53%)
FB   258.88 (+0.80%)
GOOGL   1,458.31 (-0.02%)
AMZN   3,165.82 (-0.26%)
TSLA   426.36 (+1.23%)
NVDA   526.98 (+1.07%)
BABA   277.69 (+0.61%)
CGC   14.60 (+2.74%)
MU   50.67 (+1.91%)
GE   6.07 (-2.10%)
AMD   81.42 (+2.44%)
T   28.17 (-0.74%)
F   6.57 (-1.79%)
ACB   4.97 (+3.97%)
GILD   62.16 (-1.10%)
NFLX   490.58 (-0.01%)
DIS   124.00 (-1.58%)
BA   162.84 (-1.95%)
BAC   23.61 (-1.99%)
S&P 500   3,331.64 (-0.60%)
DOW   27,383.96 (-0.73%)
QQQ   276.30 (-0.32%)
AAPL   114.04 (-0.80%)
MSFT   208.34 (-0.53%)
FB   258.88 (+0.80%)
GOOGL   1,458.31 (-0.02%)
AMZN   3,165.82 (-0.26%)
TSLA   426.36 (+1.23%)
NVDA   526.98 (+1.07%)
BABA   277.69 (+0.61%)
CGC   14.60 (+2.74%)
MU   50.67 (+1.91%)
GE   6.07 (-2.10%)
AMD   81.42 (+2.44%)
T   28.17 (-0.74%)
F   6.57 (-1.79%)
ACB   4.97 (+3.97%)
GILD   62.16 (-1.10%)
NFLX   490.58 (-0.01%)
DIS   124.00 (-1.58%)
BA   162.84 (-1.95%)
BAC   23.61 (-1.99%)
Log in
Ad MicroSmallCap
Psychedelic Stock Goes Nuts
This biotech stock focused on psychedelics is seeking to disrupt the mental health market.

7 Stocks That Will Help You Forget About the Fed in 2020

 
7 Stocks That Will Help You Forget About the FedNormally when the Federal Reserve (i.e. the Fed) makes an announcement, the market reacts predictably. That’s due, in large part, to the nature of what the Fed normally announces. Will interest rates go up, down, or remain unchanged? And for their part, the markets have a pretty good idea what the Fed will do before they do it.

But the Fed’s announcement of August 26 was a little different. They talked briefly about interest rates (they’re staying really low for a long time). But they were more concerned about inflation. Well, the Fed is always concerned about inflation, but this time they really mean it. Basic economics says that low-interest rates should spur inflation.

However, the market has been defying conventional wisdom and the Fed is not getting the inflation they want. So the Fed has basically said that they’re letting inflation go rogue. If it goes above their target 2% rate, so be it. The Fed is done trying to hit a target. At first, the markets cheered the news. Not only was the Fed not taking away the punch bowl, but they were also going to keep the low rate liquidity going for a long time!

But after a little while to digest things, investors are realizing they have to be grown-ups about this. And now investors are considering how to rebalance their portfolios for the remainder of 2020.

I don’t know about them, but if I were you I would target companies that have a high free cash flow (FCF). Whether it’s your personal finances or in evaluating a stock, cash flow is your friend.

When a corporation has high FCF, they have more strong growth in good markets and more flexibility during when the economy is weaker.

As institutional investors come back into the market, it’s time for you to reposition your portfolio for whatever comes next.

Click the "Continue to Slide #1" button to view the first company.

Psychedelic Stock Goes Nuts (Ad)

This biotech stock focused on psychedelics is seeking to disrupt the mental health market.

Click here for the full story



Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.